Triplebar utilizes synthetic biology and precision fermentation to develop biologics and sustainable food solutions, addressing global challenges such as food scarcity and healthcare needs. By providing cost-effective datasets and accelerating biological research, the company enhances the efficiency of biomanufacturing processes for diverse applications.
Funding
$21M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods of developing biologics and sustainable food solutions are often slow and expensive, hindering the ability to address pressing global challenges like food scarcity and healthcare needs. Traditional biomanufacturing processes lack the efficiency required to rapidly innovate and produce cost-effective solutions at scale.
Solution
Triplebar leverages synthetic biology, precision fermentation, and Bio AI to accelerate the development and production of biologics and sustainable food solutions. The company's platform uses evolutionary intelligence to mine biological data and create datasets that lower costs, reduce development time, and improve the relevance of biological research. By applying AI to biological engineering, Triplebar enhances the efficiency of biomanufacturing processes, enabling the creation of novel products that address critical needs in food and healthcare. The company's approach facilitates the design and engineering of products at an accelerated pace, contributing to a more sustainable and secure future.
Target Audience
Triplebar's primary customers include companies in the food and beverage industry seeking sustainable ingredients, as well as pharmaceutical and biotechnology companies developing novel biologics.
Features
- Bio AI platform that mines evolutionary data to accelerate biological research
- Precision fermentation techniques for efficient production of biologics and food ingredients
- Generative AI genomic language models for disruptive innovation
- Development of cost-effective datasets to reduce the barriers to entry in biomanufacturing
- Partnerships with established companies to scale production and distribution
- Focus on biologics for healthcare applications
- Development of sustainable and nutritious food solutions